Advertisement

Topics

Glooko, Inc. Company Profile

01:13 EDT 15th August 2018 | BioPortfolio

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-management mobile app automatically syncs data from devices including blood glucose meters, insulin pumps, CGMs, smart insulin pens and many fitness and activity trackers. The broad variety of data sources provides timely and verified information, enabling PWDs and care teams to correlate insights with diet, exercise, medication and other data. We provide care teams with an easy clinic data upload solution and a population health app so they can support PWDs during and in-between office visits. Trusted by the world’s leaders in diabetes care, we are used by 7,000 providers and over 1.5 million PWDs across 23 countries in 15 languages. Learn more by visiting www.glooko.com


News Articles [18 Associated News Articles listed on BioPortfolio]

Glooko Unveils Web-based Diabetes Analytics Platform

Diabetes management provider Glooko has unveiled new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and...

New Glooko CEO: Livongo gets a lot of press but our approach is different

Russ Johannesson pushed back on the idea that he is the CEO whose sole goal is to take the company to an exit, opined on competitors like Livongo, and said Glooko is the connective tissue across the d...

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association meeting taking place this weekend in Orlando, Fla.

Glooko’s out-of-sync moment with Novo Nordisk on its smart insulin pen project

Interviews with Glooko’s previous CEO, new CEO and a Novo Nordisk executive show that the two company’s messaging around the development of a smart insulin pen is not aligne

Data show positive results for Glooko's remote diabetes management tech

Data from a six-month pilot program showed patients with type 2 diabetes who used Glooko's remote diabetes management technol -More- 

Glooko Study Highlights Insights Into How Diabetes Healthcare Professionals Use Continuous Glucose Monitoring (CGM) Data

Poster to be presented at the 2018 American Association of Clinical Endocrinologists annual meeting Glooko, the leader in diabetes data management, today announced the ...

Glooko study sheds light on use of CGM data among diabetes healthcare professionals

Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.

Glooko Introduces New Web Analytics Platform That Includes the Most Powerful Capabilities From Diasend

New version features support for the Ambulatory Glucose Profile (AGP), new dashboards and reports Glooko, the leader in diabetes data management, today announced the de...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Glooko Enabled Remote Monitoring for Insulin-treated Patients With Type 2 Diabetes

The purpose of this study is to compare HbA1c of insulin-treated subjects with type 2 diabetes managed via usual care alone and usual care augmented with remote monitoring using Glooko

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have eithe...

Insulin Degludec Titration Using Mobile Insulin Dosing System

This is an open label randomized, controlled, parallel intervention study. Group 1 will receive usual care for insulin degludec titration using the STEP WISE degludec titration algorithm G...

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, ca...

Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes

This study will use a randomized, crossover design. Children aged 13-18 years who have been diagnosed with Type 1 diabetes for at least 1 year and with at least 2 Hemoglobin A1c values ≥...

Companies [2 Associated Companies listed on BioPortfolio]

Glooko

Glooko is the leading diabetes data management platform and is trusted by the world’s leaders in diabetes care. Over 6,000 providers in 27 countries use Glooko’s FDA-cle...

Glooko, Inc.

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-managemen...

More Information about "Glooko, Inc." on BioPortfolio

We have published hundreds of Glooko, Inc. news stories on BioPortfolio along with dozens of Glooko, Inc. Clinical Trials and PubMed Articles about Glooko, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glooko, Inc. Companies in our database. You can also find out about relevant Glooko, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Corporate Database Quicklinks



Searches Linking to this Company Record